121 related articles for article (PubMed ID: 17708067)
1. Effect of silymarin on the oral bioavailability of ranitidine in healthy human volunteers.
Rao BN; Srinivas M; Kumar YS; Rao YM
Drug Metabol Drug Interact; 2007; 22(2-3):175-85. PubMed ID: 17708067
[TBL] [Abstract][Full Text] [Related]
2. Plasma pharmacokinetics of ranitidine HCl in foals.
Holland PS; Brumbaugh GW; Ruoff WW; Brown SA
J Vet Pharmacol Ther; 1997 Dec; 20(6):447-52. PubMed ID: 9430768
[TBL] [Abstract][Full Text] [Related]
3. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
Lee HT; Lee YJ; Chung SJ; Shim CK
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability of ranitidine in healthy Mexican volunteers: effect of food.
Juárez-Olguín H; Flores J; Pérez G; Hernández G; Flores C; Guillé A; Camacho A; Toledo A; Carrasco M; Lares I
Proc West Pharmacol Soc; 2002; 45():156-8. PubMed ID: 12434565
[TBL] [Abstract][Full Text] [Related]
5. A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine.
Leucuta A; Vlase L; Farcau D; Nanulescu M
Drug Metabol Drug Interact; 2004; 20(4):273-81. PubMed ID: 15663296
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic drug interaction study: administration of ceftibuten concurrently with the antacid mylanta double- strength liquid or with ranitidine.
Radwanski E; Nomeir A; Cutler D; Affrime M; Lin CC
Am J Ther; 1998 Mar; 5(2):67-72. PubMed ID: 10099040
[TBL] [Abstract][Full Text] [Related]
7. Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine.
Chrenova J; Durisova M; Mircioiu C; Dedik L
Methods Find Exp Clin Pharmacol; 2010; 32(6):413-9. PubMed ID: 20852750
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two compartmental models for describing ranitidine's plasmatic profiles.
Schaiquevich P; Niselman A; Rubio M
Pharmacol Res; 2002 May; 45(5):399-405. PubMed ID: 12123628
[TBL] [Abstract][Full Text] [Related]
9. Effect of ketoconazole and rifampicin on the pharmacokinetics of ranitidine in healthy human volunteers: a possible role of P-glycoprotein.
Machavaram KK; Gundu J; Yamsani MR
Drug Metabol Drug Interact; 2006; 22(1):47-65. PubMed ID: 17152347
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.
Schöller-Gyüre M; Kakuda TN; De Smedt G; Vanaken H; Bouche MP; Peeters M; Woodfall B; Hoetelmans RM
Br J Clin Pharmacol; 2008 Oct; 66(4):508-16. PubMed ID: 18492125
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction study between ranitidine and metoclopramide.
Leucuţa A; Vlase L; Farcău D; Nanulescu M
Rom J Gastroenterol; 2004 Sep; 13(3):211-4. PubMed ID: 15470533
[TBL] [Abstract][Full Text] [Related]
12. The effect of ranitidine on the pharmacokinetics of rosiglitazone in healthy adult male volunteers.
Miller AK; DiCicco RA; Freed MI
Clin Ther; 2002 Jul; 24(7):1062-71. PubMed ID: 12182252
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of oral ranitidine in Mexicans.
Castañeda-Hernández G; Flores-Murrieta FJ; Granados-Soto V; Herrera-Abarca A; Pérez-Urizar J; Herrera JE; Hong E
Arch Med Res; 1996; 27(3):349-52. PubMed ID: 8854394
[TBL] [Abstract][Full Text] [Related]
14. Applications and simulations of a discontinuous oral absorption pharmacokinetic model.
Witcher JW; Boudinot FD
Pharm Res; 1996 Nov; 13(11):1720-4. PubMed ID: 8956341
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of a formulation containing a diclofenac-ranitidine combination.
Carrasco-Portugal Mdel C; Aguilar-Cota ME; Pérez-Urizar J; Cabrera O; Herrera JE; Flores-Murrieta FJ
Proc West Pharmacol Soc; 2002; 45():8-10. PubMed ID: 12434510
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers.
Cho HY; Yoon H; Park GK; Lee YB
Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013
[TBL] [Abstract][Full Text] [Related]
18. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Knych HK; Stanley SD; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
[TBL] [Abstract][Full Text] [Related]
19. Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
Klein CE; Chiu YL; Cai Y; Beck K; King KR; Causemaker SJ; Doan T; Esslinger HU; Podsadecki TJ; Hanna GJ
J Clin Pharmacol; 2008 May; 48(5):553-62. PubMed ID: 18440920
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence of ranitidine and bismuth derived from two compound preparations.
Zhou Q; Ruan ZR; Yuan H; Jiang B; Xu DH
World J Gastroenterol; 2006 May; 12(17):2742-8. PubMed ID: 16718762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
